Role of Tranexamic Acid for Reducing Blood Loss in Patients Undergoing Major Gastro-intestinal Surgery

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Primary objective of the study is to compare requirement of blood transfusion and mortality in patients receiving Tranexamic acid (Cyklokapron®) and those not receiving it. Secondary objective is to; assess the re-bleeding events; need for surgical intervention; length of stay in Intensive care unit in between the two groups.
Epistemonikos ID: 78972e4a88c980df616f86991e1b28361ee4cda2
First added on: May 11, 2024